{"DataElement":{"publicId":"2935895","version":"1","preferredName":"Philadelphia Chromosome Positive Finding Metaphase Laboratory Procedure Outcome Percentage Integer::0 Decimal Place Value","preferredDefinition":"The 0 decimal place numeric laboratory value measured, assigned or computed related to the assessment of philadelphia chromosome positive metaphases in a specimen.","longName":"2935538v1.0:3061015v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2935538","version":"1","preferredName":"Philadelphia Chromosome Positive Finding Metaphase","preferredDefinition":"A translocation between chromosomes 9 and 22. It is the hallmark for chronic myelogenous leukemia (CML)._An observation confirming something, such as the presence of a disease, condition, or microorganism._The second phase of mitosis, in which the chromosomes line up across the equatorial plane of the spindle prior to separation.","longName":"2935535v1.0:3111292v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2935535","version":"1","preferredName":"Philadelphia Chromosome","preferredDefinition":"An abnormality of chromosome 22 in which part of chromosome 9 is transferred to it.  Bone marrow cells that contain the Philadelphia chromosome are often found in chronic myelogenous leukemia.","longName":"C28452","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Philadelphia Chromosome","conceptCode":"C28452","definition":"A translocation between chromosomes 9 and 22. It is the hallmark for chronic myelogenous leukemia (CML).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"71F88553-C510-17CC-E040-BB89AD43398B","latestVersionIndicator":"Yes","beginDate":"2009-08-25","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-08-25","modifiedBy":"ONEDATA","dateModified":"2009-08-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3111292","version":"1","preferredName":"Positive Finding Metaphase","preferredDefinition":"An observation confirming something, such as the presence of a disease, condition, or microorganism.:Arrangement of chromosomes in the equatorial plane of the central spindle to form the monaster.  Chromosomes separate into exactly similar halves. (NCI)","longName":"C38758:C16846","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Metaphase Process","conceptCode":"C16846","definition":"The second phase of mitosis, in which the chromosomes line up across the equatorial plane of the spindle prior to separation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"894FFBD5-AC96-5061-E040-BB89AD435F93","latestVersionIndicator":"Yes","beginDate":"2010-06-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-06-18","modifiedBy":"ONEDATA","dateModified":"2010-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"71F88553-C532-17CC-E040-BB89AD43398B","latestVersionIndicator":"Yes","beginDate":"2009-08-25","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-08-25","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3061015","version":"1","preferredName":"Laboratory Procedure Outcome Percentage Integer::0 Decimal Place Value","preferredDefinition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._The result of an action._A fraction or ratio with 100 understood as the denominator._A number with no fractional part, including the negative and positive numbers as well as zero.::0_An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers._A numerical quantity measured or assigned or computed.","longName":"3061015v1.0","context":"NHLBI","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","unitOfMeasure":"%","minLength":null,"maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":"0","format":"%","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3061014","version":"1","preferredName":"Laboratory Procedure Outcome Percentage Integer::0 Decimal Place Value","preferredDefinition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.:Outcome; a phenomenon that follows and is caused by some previous phenomenon.:Percentage; a fraction or ratio with 100 understood as the denominator.:A number with no fractional part.::0:An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers.:A numerical quantity measured or assigned or computed.","longName":"C25294:C20200:C25613:C45255::0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Decimal Place","conceptCode":"C42646","definition":"An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8446A1A4-4444-2A88-E040-BB89AD43255A","latestVersionIndicator":"Yes","beginDate":"2010-04-15","endDate":null,"createdBy":"WHITES","dateCreated":"2010-04-15","modifiedBy":"ONEDATA","dateModified":"2010-04-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8446A1A4-4455-2A88-E040-BB89AD43255A","latestVersionIndicator":"Yes","beginDate":"2010-04-15","endDate":null,"createdBy":"WHITES","dateCreated":"2010-04-15","modifiedBy":"NYCHM","dateModified":"2010-12-02","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964905","version":"1","longName":"2112r1: CML Post-HSCT Data","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"cml_post_trt_resp_ph_rst","type":"NMDP_FN","context":"NHLBI"},{"name":"PerformedClinicalResult:value","type":"HCT_BRIDG","context":"NHLBI"},{"name":"CMLF_DABR_kary_ph_chr_meta_pct","type":"NMDP_FN","context":"NHLBI"},{"name":"CMLF_PHPI_kary_ph_chr_meta_pct","type":"NMDP_FN","context":"NHLBI"},{"name":"CMLP_LSDX_kary_ph_chr_meta_pct","type":"NMDP_FN","context":"NHLBI"},{"name":"CMLP_LSLE_kary_ph_chr_meta_pct","type":"NMDP_FN","context":"NHLBI"},{"name":"CMLP_LTHM_kary_ph_chr_meta_pct","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"Specify the Philadelphia chro","type":"Preferred Question Text","description":"Specify the Philadelphia chromosome positive metaphases value (%):","url":null,"context":"NHLBI"},{"name":"BRIDG mapping for CDE:2935895","type":"BRIDG Mapping Path","description":"PerformedClinicalResult.value WHERE PerformedClinicalResult > PerformedObservation > DefinedObservation.nameCode = \"test for Philidelphia chromosome positive metaphase\"","url":null,"context":"NHLBI"},{"name":"% Ph+ metaphases (t(9;22)(q34;q11) and variants)","type":"Application Standard Question Text","description":"% Ph+ metaphases (t(9;22)(q34;q11) and variants)","url":null,"context":"NHLBI"},{"name":"% Ph+ metaphases (t(9;22)(q34;q11) and variants)","type":"Alternate Question Text","description":"% Ph+ metaphases (t(9;22)(q34;q11) and variants)","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"71F8C85B-6F6C-9265-E040-BB89AD433FDD","latestVersionIndicator":"Yes","beginDate":"2009-08-25","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-08-25","modifiedBy":"ALEYR","dateModified":"2019-04-13","changeDescription":". .1/8/14mn-added Bridg info. System generated def displayed as alt def. AK 6/4/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}